About Liver India
Liver India is India’s premier healthcare centre
World-Class Transplant Oncology | Cholangiocarcinoma Expertise | High-Success Liver Transplant Surgery with Exceptional Living Donor Liver Transplant Outcomes
About Liver India - Leading in Liver Transplant Oncology
Liver India is founded and led by Dr. Karthik Mathivanan, a globally recognized pioneer in transplant oncology with over 15 years of experience in multi-organ transplant surgery, including liver transplants. His expertise spans various procedures, such as liver, small bowel, kidney, and pancreatic transplantation, serving patients across India, Asia, Europe, and the Middle East, including those battling cholangiocarcinoma.
Dr. Karthik began his career at Apollo Hospitals before advancing through some of India's most prestigious institutions — Medanta The Medicity, Chettinad Hospital and Research Institute, and MGM Healthcare. He currently serves as Program Director of Liver and Multi-Organ Transplant at MIOT International in Chennai and is a founding member of India's Liver Transplant Society.
Having worked at the front line of liver disease for over a decade, Dr. Karthik understands the myths, misinformation, and anxieties patients face regarding transplant surgery — and is committed to replacing fear with clarity and uncertainty with expert care.
Global Leaders in Transplant Oncology
High-Success Live Donor Liver Transplant (LDLT)
High-Success Live Donor Liver Transplant (LDLT)
Intrahepatic cholangiocarcinoma (iCC), along with hilar cholangiocarcinoma, are critical considerations in liver transplant evaluations. Additionally, multifocal and giant hepatocellular carcinoma (HCC) may necessitate TARE plus immunotherapy for effective downstaging prior to transplant surgery. Managing high-risk tumours is crucial, especially given the potential for recurrence after resection or ablation.
High-Success Live Donor Liver Transplant (LDLT)
High-Success Live Donor Liver Transplant (LDLT)
High-Success Live Donor Liver Transplant (LDLT)
With over 2000 complex liver surgeries performed, our facility has achieved zero donor mortality rates, even in challenging cases such as cholangiocarcinoma. We specialize in ABO-incompatible liver transplants (LDLT) and dual-graft LDLT, catering to elderly and high-risk transplant patients. Our innovative approach includes machine-perfused grafts, utilizing techniques like HOPE and NMP to enhance outcomes in transplant surgery.
Pioneering Cholangiocarcinoma Transplants
High-Success Live Donor Liver Transplant (LDLT)
Pioneering Cholangiocarcinoma Transplants
Locally Advanced cholangiocarcinoma cases have shown promising results with TARE + immunotherapy converted cases. This approach is particularly relevant for multifocal cholangiocarcinoma patients seeking options such as liver transplant or transplant surgery, contributing to the stories of long-term survivors.
Stay up to date with our Instagram
Copyright © 2026 Liver India - All Rights Reserved.